📰 2 sources covering this story

The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews

First covered 19 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews
NPR
NPR1 hrs ago
The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews
It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
Haaretz
Haaretz🏁 first to report19 hrs ago
The devil wears Galliano? • Met Gala honor for designer disgraced by antisemitism gets mixed reviews
The devil wears Galliano? • Met Gala honor for designer disgraced by antisemitism gets mixed reviews  Haaretz
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →